Routine unselected access to day case electrical cardioversion of persistent atrial fibrillation: Anticoagulant preparation is the key factor

Scottish Medical Journal

Volumn 49, Issue 1, 2004, Pages 26-29

  Wilshire, J ^a   Bohm A ^a   MacFadyen, Robert J ^a  

^a RAIGMORE HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation; Cancellations; Case turnove; Poor warfarin titration; Routine electrical cardioversion; Rural dependence

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; FLECAINIDE; SOTALOL; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; GEOGRAPHY; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL SERVICE; PROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 1542374738     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693300404900107     Document Type: Article

References (24)

1. Pelosi F, Morady F. Evaluation and management of atrial fibrillation. Med Clin N. America 2001 85: 225-246
2. Lipkin DP, Frenneaux M, Stewart R, Joshi J, Lowe T, McKenna WJ. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinusrhythm. Br Heart J. 1988 59:572-7.
3. May CD, Davis MJ. The safety and economic advantages of day case electrophysiologic studies. Aust N Z J Med. 1992 22(3): 240-2.
4. Schwartzman D, Musley SK, Swerdlow C, Hoyt RH, Warman EN. Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol. 2002 40:93-9.
5. Hampton JR, Gray A. The future of general medicine: lessons from a general admissions ward. J. Roy Coll. Phys. Lond. 1998; 32: 39-43.
6. Lip GYH, Zarifis J, Watson RDS, Beevers DG. Physician variation in the management of patients with atrial fibrillation. Heart 1996; 75: 200-205.
7. Berry C, Stewart S, Payne EM, McArthur JD, McMurray JJV. Electrical cardioversion for atrial fibrillation: outcomes in "real life" clinical practice. Int. J. Cardiol. 81:29-35.
8. Van Gelder IC, Hagens VE, Bosker HA et al, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New Eng J, Med. 2002; 347: 1834-1840.
9. Levy T, Walker S, Mason M, Spurrell P, Rex S, Brant S, Paul V. Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study. Heart 2001; 85: 171-178.
10. Lumer GB, Roy Talajic M, Couturier A et al Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur. Heart J. 2002; 23: 1050-1056.
11. Raipancholia R, Sentinella L, Lynch M. Role of conscious sedation for external cardioversion. Heart 2001; 86: 571-572.
12. Goldner BG, Baker J, Accordino A, Sagatino L, DiGiulio M, Kalenderian D, Lin D, Zambrotta V, Stechel J, Maccaro P, Jadonath R. Electrical cardioversion of atrial fibrillation or flutter with conscious sedation in age of cost containment. Amer. Heart J. 1998: 136: 961-964.
13. Stoneham MD. Anaesthesia for cardioversion. Anaes 1996; 51: 565-570.
14. Gale DW, Grissom TE, Mirenda JV. Titration of intravenous anesthetics for cardioversion - Comparison of propofol; methohexital and midazolam. Crit. Care Med. 1993; 21: 1509-1513.
15. Nishino M, Hoshida S, Tanouchi J, Ito T, Kato J, Iwai K, Tanahashi H, Hori M, Yamada Y, Kamada T. Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol. 2000 85:1451-4.
16. Mattioli AV, Castelli A, Andria A, Mattioli G. Clinical and echocardiographic features influencing recovery of atrial function after cardioversion of atrial fibrillation. Am J Cardiol. 1998 82:1368-71
17. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with non-rheumatic atrial fibrillation. New Eng. J. Med. 1996; 335: 540-6.
18. Matchar DB, Samsa GP, Cohen SJ, Oddone EZ, Jurgelski AE. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: Results of the Managing Anticoagulation Services Trial. Am. J. Med. 2002, 113:42-51.
19. Hirri HM, Green PJ. Audit of anticoagulant therapy and acute hospital admissions. Clin. Lab. Haematol. 2002; 24: 43-45.
20. Lip GYH, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br. Heart. J. 1994; 71: 92-95.
21. Schreiber TL, Elkhatib A, Grines CL, O'Neill WW. Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J. Am. Coll. Cardiol. 1995; 26: 577-582.
22. Catherwood E, Fitzpatrick WD, Greenberg ML, Holzberger PT, Malenka DJ, Gerling BR, Birkmeyer JD. Cost effectiveness of cardioversion and anti-arrhythmic therapy in non-valvular atrial fibrillation. Ann. Int. Med. 1999; 130: 625-630.
23. Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur. Heart J. 2000 21:66-73.
24. Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med 1987 Apr;106(4):503-6.